A cautionary tale of how to waste a good product - Recensione dipendente - Dipendente anonimo presso C2N Diagnostics

2,0
21 mar 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Blood based biomarkers are the future in diagnostics and having put all their investment in allowing for the ability to scale with a mass spec pipeline was an excellent move. The science and tech are sound.

Svantaggi

I have never seen a company so small have so much infighting. The amount petty behavior is crazy. People are constantly talking behind each others backs, at all levels. Massive gaps in knowledge in the regulatory, compliance and legal side of things. Either extreme caution or ignorance or both, regularly results in inaction. Squandered tech lead and now competitors have caught up and surpassed us.

Esplora altre recensioni su C2N Diagnostics

5,0
13 feb 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Competent, good humored people with a worthwhile mission. Good pay and decent benefits.

Svantaggi

General difficulties of remote work

1,0
8 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good technology, some employees offered remote work

Svantaggi

Worst leadership team ever. Lab led by a scientist who never operated a lab, Clinical Trial business led by a mumbler with no business sense. Finance has zero influence, many decisions made without his knowledge. Medical spins yarn in a silo. Commercial leadership is appalling, first guy was a bully, new guy is a sycophant. HR, total joke. Legal makes most decisions. CEO is feckless, focuses more on personal prestige than on viability of the business. Incredible that the company made it this far. This fish rots from the head.

Vedi recensioni per: Utile|Valutazione|Data|Tutto